Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC weekly Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E41.07 EPS (ttm)0.95 Insider Own0.50% Shs Outstand2.62B Perf Week3.28%
Market Cap102.35B Forward P/E19.18 EPS next Y2.03 Insider Trans0.00% Shs Float2.61B Perf Month-0.10%
Income2.41B PEG2.13 EPS next Q0.31 Inst Own19.90% Short Float0.85% Perf Quarter-5.98%
Sales22.40B P/S4.57 EPS this Y-9.60% Inst Trans2.67% Short Ratio4.22 Perf Half Y-3.27%
Book/sh4.14 P/B9.43 EPS next Y20.36% ROA3.90% Target Price46.10 Perf Year5.92%
Cash/sh1.89 P/C20.64 EPS next 5Y19.30% ROE20.30% 52W Range34.38 - 43.29 Perf YTD2.74%
Dividend1.40 P/FCF- EPS past 5Y-3.60% ROI10.90% 52W High-9.87% Beta0.47
Dividend %3.59% Quick Ratio0.60 Sales past 5Y-3.10% Gross Margin79.90% 52W Low13.50% ATR0.61
Employees64400 Current Ratio0.70 Sales Q/Q6.00% Oper. Margin16.90% RSI (14)53.27 Volatility1.33% 1.32%
OptionableYes Debt/Eq2.06 EPS Q/Q74.30% Profit Margin10.70% Rel Volume0.58 Prev Close38.66
ShortableYes LT Debt/Eq1.70 EarningsApr 26 BMO Payout47.50% Avg Volume5.28M Price39.02
Recom1.60 SMA202.82% SMA50-1.86% SMA2000.08% Volume3,085,118 Change0.93%
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
May-22-19 07:00AM  Bob Harper and AstraZeneca Expand Survivors Have Heart Initiative to Empower and Unite Heart Attack Survivors Nationwide Business Wire
May-21-19 02:27AM  Despite Its High P/E Ratio, Is AstraZeneca PLC (LON:AZN) Still Undervalued? Simply Wall St.
May-20-19 12:31PM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
08:00AM  FASENRA® (benralizumab) reduces oral corticosteroid use and maintains long-term efficacy and safety profile in severe eosinophilic asthma Business Wire
May-17-19 09:05AM  Rigel Initiates Enrollment in Pivotal Blood Disorder Study Zacks
May-16-19 08:00AM  AstraZeneca Continues to Redefine Cancer Treatment at The 2019 ASCO Annual Meeting Business Wire
May-15-19 09:07AM  3 Top Diabetes Stocks to Watch in May Motley Fool
May-14-19 11:51AM  AstraZeneca Needs New Breast Cancer Drug to be Blockbuster GuruFocus.com
May-11-19 02:51AM  AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark Zacks
May-10-19 03:29PM  AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark Zacks
10:21AM  Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates Zacks
07:34AM  Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug Zacks
May-09-19 01:30AM  AstraZeneca Gets an $8 Billion Punishment Bloomberg
May-08-19 09:46AM  Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong Zacks
07:00AM  AstraZeneca Teams Up with PGA Golf Champion Jason Day to Raise Awareness about the Importance of Biomarker Testing in Lung Cancer Business Wire
May-07-19 10:53AM  Guardant Health (GH) to Report Q1 Earnings: What's in Store? Zacks
May-03-19 09:00AM  Change Makers Across the Oncology Community Recognized at 2019 Cancer Community (C2) Awards Business Wire
08:36AM  Ironwood (IRWD) Q1 Earnings & Revenues Miss, Shares Fall Zacks
May-02-19 11:47AM  Edited Transcript of AZN.L earnings conference call or presentation 26-Apr-19 11:00am GMT Thomson Reuters StreetEvents
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
03:05AM  AstraZeneca ties up with France's Transgene to develop viral immunotherapies Reuters
May-01-19 08:50AM  BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery TechCrunch
02:23AM  An Intrinsic Calculation For AstraZeneca PLC (LON:AZN) Suggests It's 46% Undervalued Simply Wall St.
Apr-30-19 01:00PM  Health Care Stocks: Buy Them While They're Down Kiplinger
11:39AM  AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up? Zacks
09:48AM  Merck (MRK) Beats on Q1 Earnings & Sales as Keytruda Shines Zacks
Apr-29-19 05:08PM  Better Big Pharma Stock: AbbVie vs. AstraZeneca Motley Fool
02:20PM  Md. biotech files to go public in up to $92M offering American City Business Journals
Apr-26-19 06:31PM  AstraZeneca PLC (AZN) Q1 2019 Earnings Call Transcript Motley Fool
04:20PM  This Drug Giant Nearly Doubled Its Earnings So Why Are Shares Slipping? Investor's Business Daily
11:13AM  This Drug Giant Nearly Doubled Its Earnings So Why Are Shares Slipping? Investor's Business Daily
10:59AM  AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales Zacks
09:29AM  Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales Zacks
09:23AM  AstraZeneca, RBS earnings weigh on London markets MarketWatch
06:45AM  Newer drugs fuel AstraZeneca quarterly sales beat Reuters
05:41AM  AstraZeneca's first quarter profits jump 74% Associated Press
05:41AM  Astrazeneca: 1Q Earnings Snapshot Associated Press
05:26AM  AstraZeneca first-quarter sales beat estimates on cancer drugs Reuters
03:58AM  AstraZeneca first-quarter sales beat estimates on cancer drugs Reuters
03:20AM  AstraZeneca Cancer Drug Sales Fuel Profit Beating Estimates Bloomberg
02:56AM  AstraZeneca cancer drugs drive growth in sales Financial Times
Apr-25-19 09:55AM  Bayer (BAYRY) Q1 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Apr-24-19 12:00AM  AstraZeneca chief claims vindication five years after Pfizer bid Financial Times
Apr-23-19 10:44AM  What's in the Cards for AstraZeneca (AZN) in Q1 Earnings? Zacks
Apr-18-19 09:38AM  AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why Zacks
Apr-17-19 11:06AM  Top Ranked Income Stocks to Buy for April 17th Zacks
Apr-15-19 09:57AM  Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer Zacks
05:28AM  London's FTSE 100 tugged down by miners; IWG lifts midcaps Reuters
Apr-12-19 10:30AM  Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal Zacks
09:55AM  Dow 30 Stock Roundup: Procter & Gamble Hikes Dividend, Boeing Q1 Commercial Deliveries Fall Zacks
Apr-10-19 03:24PM  Here's what to expect from the stock market next month Investopedia
11:11AM  Is AstraZeneca Stock Worth Buying Before Earnings? InvestorPlace
10:46AM  Alkermes Reports Positive Data From Schizophrenia Study Zacks
10:20AM  J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store? Zacks
10:14AM  AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer Zacks
Apr-09-19 11:24AM  PhaseBio Stock Up on Breakthrough Therapy Status for PB2452 Zacks
10:30AM  Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457 Zacks
Apr-08-19 09:41AM  The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca Zacks
03:04AM  Is AstraZeneca PLC's (LON:AZN) Balance Sheet A Threat To Its Future? Simply Wall St.
Apr-07-19 10:33PM  City of London alarmed at EUs no-deal Brexit equity trading plan Financial Times
Apr-06-19 03:41AM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
Apr-05-19 09:26PM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
10:34AM  Will Ironwood Suffer From Dependence on Linzess' Progress? Zacks
10:20AM  Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU Zacks
09:33AM  Myriad Genetics Expands CDx Tie Up With AstraZeneca & Merck Zacks
01:15AM  Investors Chronicle: Hostelworld. YouGov, AstraZeneca Financial Times
Apr-04-19 10:36AM  Inovio's HPV Candidate Shows Efficacy in Pilot Study, Stock Up Zacks
Apr-03-19 10:22AM  Clovis Posts Data on Rubraca Study for Pancreatic Cancer Zacks
07:23AM  Daiichi Sankyo Company, Limited -- Moody's: Daiichi Sankyo's collaboration with AstraZeneca is positive for the former's oncology franchise Moody's
Apr-02-19 11:15AM  AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion Barrons.com
10:04AM  Merck's Keytruda Gets Nod for First-Line Lung Cancer in China Zacks
09:44AM  Advaxis Up on Positive Early-Stage Immunotherapy Study Data Zacks
06:53AM  Stocks to watch: Rolls-Royce, Lyft, AstraZeneca, Fevertree, Pandora Financial Times
06:32AM  Zeneca Wilmington Inc. -- Moody's changes outlook on AstraZeneca's A3 ratings to stable; affirms ratings Moody's
Apr-01-19 03:36PM  AstraZeneca's Selumetinib Gets Breakthrough Therapy Status Zacks
12:12PM  The Dow Is Gaining Because Good News From China Is Good News for Stocks Barrons.com
11:19AM  AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation Benzinga
06:30AM  Selumetinib Granted US Breakthrough Therapy Designation in Neurofibromatosis Type 1 Business Wire
Mar-29-19 04:47PM  AVEO Pharmaceuticals (AVEO) to File NDA for Fotivda with FDA Zacks -5.93%
04:33PM  Why AstraZeneca, Yeti Holdings, and CannTrust Holdings Slumped Today Motley Fool
01:41PM  FTSE 100 gains as trade progress offsets latest Brexit setback Reuters
12:48PM  AstraZeneca (AZN) Signs $6.9B Cancer Deal with Daiichi Sankyo Zacks
11:30AM  Japan's Daiichi Strikes Cancer Therapy Deal With AstraZeneca Worth Up To $6.9B Benzinga
10:42AM  Mondelez may be shopping, AstraZeneca makes major deal, Tim Cook may testify Yahoo Finance
10:34AM  AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal Reuters
10:19AM  Mondelez may be shopping, AstraZeneca makes major deal, Tim Cook may testify Yahoo Finance Video
09:28AM  AstraZeneca in cancer deal with Daiichi Sankyo Associated Press
09:10AM  AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal Reuters
09:06AM  RH Stock Tumbles, AstraZeneca Slides and 3 More Friday Morning Movers Barrons.com
08:42AM  AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal Reuters
08:16AM  AstraZeneca Slides on $6.9 Billion Cancer Drug Deal with Japan's Daiichi Sankyo TheStreet.com
08:10AM  Stocks to watch: AstraZeneca, Tui, H&M, Auto Trader, Jupiter, Evraz Financial Times
08:06AM  Is This a Drug Deal or a Rights Offering? Bloomberg
06:43AM  AstraZeneca Bets $6.9 Billion in Japan Cancer Therapy Deal Bloomberg
03:51AM  Nikkei up on U.S.-China trade talk optimism; Daiichi Sankyo jumps Reuters
12:46AM  AstraZeneca in $6.9bn cancer deal with Daiichi Sankyo Financial Times
Mar-28-19 08:08PM  AstraZeneca and Daiichi Sankyo to jointly develop cancer drug Reuters
01:29PM  European shares give up gains as banks weigh amid concerns on growth, Brexit Reuters
10:43AM  AstraZeneca's Forxiga Gets Nod in Japan for Type I Diabetes Zacks
04:44AM  There's a feeling of 'deep uncertainty': AstraZeneca CNBC Videos
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a collaboration and license option agreement with Transgene SA for clinical development and commercialization of novel oncolytic immunotherapies. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 22Buy5.00600,0003,000,0003,004,554Oct 24 04:16 PM
ASTRAZENECA PLC10% OwnerSep 28Buy15.00246,6663,699,9902,164,855Oct 02 09:35 PM